Halpern Financial’s AbbVie ABBV Stock Holding History

Halpern Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$31.9K	Buy	162 +12	+8%	+$2.24K	0.01%	105
2024 Q2	$25.7K	Sell	150 -50	-25%	-$8.28K	0.01%	115
2024 Q1	$35.5K	Hold	200	–	–	0.01%	106
2023 Q4	$32.1K	Buy	200 +50	+33%	+$7.29K	0.01%	117
2023 Q3	$22.4K	Hold	150	–	–	0.01%	121
2023 Q2	$20.2K	Sell	150 -100	-40%	-$14.7K	0.01%	115
2023 Q1	$39.8K	Hold	250	–	–	0.01%	85
2022 Q4	$40.4K	Hold	250	–	–	0.01%	88
2022 Q3	$33.6K	Sell	250 -30	-11%	-$4.3K	0.01%	89
2022 Q2	$42.9K	Sell	280 -170	-38%	-$26K	0.02%	89
2022 Q1	$73K	Hold	450	–	–	0.03%	84
2021 Q4	$60.9K	Buy	450 +99	+28%	+$11.7K	0.03%	76
2021 Q3	$37.9K	Buy	351 +175	+99%	+$20K	0.02%	81
2021 Q2	$19.8K	Hold	176	–	–	0.01%	101
2021 Q1	$19K	Buy	176 +126	+252%	+$13.5K	0.01%	98
2020 Q4	$5.36K	Hold	50	–	–	﹤0.01%	160
2020 Q3	$4.38K	Hold	50	–	–	﹤0.01%	163
2020 Q2	$4.91K	Hold	50	–	–	﹤0.01%	132
2020 Q1	$3.81K	Sell	50 -8	-14%	-$681	﹤0.01%	131
2019 Q4	$5.13K	Buy	+58	New	+$4.82K	﹤0.01%	150

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Halpern Financial's ABBV Position: Q3 2024 in Review

Halpern Financial increased its AbbVie (ABBV) stake by 8% in Q3 2024, buying an estimated $2.24K and bringing the position to 162 shares worth $31.9K. The position accounts for 0.01% of the portfolio, ranked #105.

Halpern Financial first reported a position in ABBV in Q4 2019 and has held it in 20 quarters since. The position peaked at $73K in Q1 2022. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Halpern Financial held 162 shares of AbbVie worth $31.9K as of Q3 2024.
Halpern Financial bought 12 AbbVie shares in Q3 2024, an estimated $2.24K.
AbbVie made up 0.01% of Halpern Financial's portfolio in Q3 2024, its #105 holding.
Halpern Financial first reported a position in AbbVie in Q4 2019 and has held it in 20 quarters since.
Halpern Financial's AbbVie position peaked at $73K in Q1 2022.
3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.